Canada's Gildan to acquire US apparel brand HanesBrands for $4.4bn
The transaction will combine the strengths of both companies to create what is described as a 'global basic apparel leader'.
The merger will expand Gildan's scale and strengthen its market positioning, combining its activewear leadership with HanesBrands' innerwear retail expertise.
Gildan president and CEO Glenn Chamandy stated: 'With this transaction, our revenues will double and we achieve a scale that distinctly sets us apart. The combination with HanesBrands strengthens our positioning with an opportunity to expand the heritage Hanes brand presence in activewear across channels, while enhancing Gildan's retail reach for its portfolio of brands.'
Gildan's headquarters will remain in Montréal, Québec, with a combined presence in Winston-Salem, North Carolina.
HanesBrands shareholders will receive 0.102 common shares of Gildan and $0.80 in cash for each share of HanesBrands stock, owning 19.9% of Gildan shares post-transaction.
The transaction, subject to shareholder and regulatory approvals, is expected to close between late 2025 and early 2026.
The combined company will benefit from enhanced product diversification, an advanced low-cost manufacturing network and significant synergy opportunities, with at least $200m in annual cost synergies expected by 2028.
Gildan has obtained $2.3bn of committed financing for the acquisition and anticipates a net debt leverage ratio of 2.6 times adjusted earnings before interest, taxes, depreciation and amortisation at closing.
Gildan has reaffirmed its full-year 2025 revenue and earnings per share guidance and provided a three-year outlook for 2026 to 2028, anticipating 3% to 5% net sales growth, 3% to 4% capital expenditures annually to support growth and vertical integration, and enhanced shareholder returns.
HanesBrands board of directors chairman Bill Simon stated: 'As part of Gildan, HanesBrands will benefit from an even stronger financial and operational foundation that will provide new growth opportunities – helping to power further innovation, a broader product offering and greater reach across channels and geographies. We are confident that this transaction and the next chapter with Gildan is the right next step for HanesBrands and will honour and build on its long history for the benefit of all our stakeholders.'
Morgan Stanley & Co and CIBC Capital Markets acted as financial advisors to Gildan while Sullivan & Cromwell and Stikeman Elliott as legal advisors.
Goldman Sachs & Co and Evercore served as lead financial advisors to Hanesbrands, and Jones Day and Blake, Cassels & Graydon were legal advisors.
"Canada's Gildan to acquire US apparel brand HanesBrands for $4.4bn" was originally created and published by Retail Insight Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
AmpliTech Group Inc (AMPG) Q2 2025 Earnings Call Highlights: Record Sales and Strategic ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AmpliTech Group Inc (NASDAQ:AMPG) achieved record sales of over $11 million in Q2 2025, surpassing total sales for the entire 2024 fiscal year. The company has a strong financial position with $16,423,000 in cash and cash equivalents and no long-term debt. AmpliTech Group Inc (NASDAQ:AMPG) has secured multiple purchase orders and LOIs with prominent 5G players, indicating strong future revenue potential. The company is strategically positioned to benefit from major US government initiatives, including rural broadband funding and the CHIPS Act. AmpliTech Group Inc (NASDAQ:AMPG) is the only US-based company providing complete vertically integrated end-to-end commercial and defense-grade networking solutions, offering a trusted alternative to foreign suppliers. Negative Points The company experienced lower than normal gross profit margins in Q2 2025 due to front-loaded investments and one-time costs. AmpliTech Group Inc (NASDAQ:AMPG) incurred several one-time costs, including license fees and initial production line fees, which impacted profitability. The quantum computing business is not yet at a production phase, limiting immediate revenue potential from this segment. The satellite business is expected to start generating revenue only next year, indicating a delay in realizing returns from this division. The company had to expedite material and pay premiums to meet Q2 delivery requirements, which increased costs and affected margins. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with AMPG. Q: Can you provide more details on the orders from the second tier one customer and the expected timeline for additional orders? A: We have already received orders from the second tier one customer, which are part of our backlog. We have two main Letters of Intent (LOIs), one for $170 million and another for $40 million. We have actively shipped against the $40 million LOI during Q2 and received additional orders for production quantities for this year and the start of next year. For the $170 million LOI, we have received about $2.5 million worth of orders, with the bulk expected between 2026 and 2027. George Flores, COO Q: How is the pipeline looking with other operators around the world? A: While we can't provide specific numbers, the transition to 5G OAN technology is imminent for many other MNOs. Our successful implementation with current partners has made it more viable for other large MNOs to pursue this opportunity. We expect a positive response from other MNOs next year. Pava McGul, CEO Q: Can you update us on the progress in the quantum computing space? A: Quantum computing is not yet at a production phase. We have delivered products to large companies, but the market is still in R&D. Quantum computing will eventually power AI, replacing current silicon applications. When production ramps up, our components will be essential, but this is not expected immediately. Pava McGul, CEO Q: What is the status of your space division and the backlog for next year? A: Our space products are geared towards low Earth orbit applications. The satellite business is expected to start next year as satellites are being built out. We have developed space-qualified hardware to support these applications, but significant demand is anticipated to begin next year. Pava McGul, CEO Q: How are you managing inventory and manufacturing to meet demand? A: We have a strong relationship with our customers, allowing us to see their forecasts and activate our supply chain accordingly. This has helped us avoid expediting costs and manage inventory effectively. We are building to order and keeping inventory levels manageable to support upcoming orders across our divisions. George Flores, COO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
19 minutes ago
- Yahoo
Asian Market Insights: CNMC Goldmine Holdings And 2 Other Noteworthy Penny Stocks
As global markets respond to economic data and rate cut speculations, Asian indices have shown resilience amid these shifting dynamics. In this context, penny stocks—often representing smaller or newer companies—remain a relevant investment area despite their somewhat outdated label. By focusing on those with robust financials, investors can uncover potential opportunities for growth; here we examine CNMC Goldmine Holdings and two other noteworthy examples that may offer both stability and upside in the evolving market landscape. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.06 THB4.01B ★★★★★☆ Lever Style (SEHK:1346) HK$1.47 HK$909.23M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.49 HK$2.07B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.645 SGD261.41M ★★★★★☆ China Sunsine Chemical Holdings (SGX:QES) SGD0.69 SGD657.83M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.91 SGD11.45B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.96 THB1.41B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.76 THB9.62B ★★★★★★ BRC Asia (SGX:BEC) SGD3.50 SGD960.23M ★★★★★★ Click here to see the full list of 972 stocks from our Asian Penny Stocks screener. Let's uncover some gems from our specialized screener. CNMC Goldmine Holdings Simply Wall St Financial Health Rating: ★★★★★☆ Overview: CNMC Goldmine Holdings Limited is an investment holding company focused on the exploration and mining of gold deposits in Malaysia, with a market cap of SGD261.41 million. Operations: The company generates revenue primarily from its mining operations, totaling $88.33 million. Market Cap: SGD261.41M CNMC Goldmine Holdings has demonstrated robust financial performance, with earnings growing by 210.3% over the past year, significantly outpacing the industry. The company reported a net income of US$15.76 million for H1 2025, up from US$4.43 million the previous year, reflecting strong operational efficiency and high-quality earnings. Its short-term assets (US$51.3M) comfortably cover both short- and long-term liabilities, indicating solid financial health. Despite significant insider selling recently and an unstable dividend track record, CNMC's seasoned management team and favorable valuation compared to peers suggest potential for continued growth in this volatile sector. Click here to discover the nuances of CNMC Goldmine Holdings with our detailed analytical financial health report. Gain insights into CNMC Goldmine Holdings' future direction by reviewing our growth report. LifeTech Scientific Simply Wall St Financial Health Rating: ★★★★★★ Overview: LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases across Mainland China and other international markets, with a market cap of approximately HK$10.04 billion. Operations: The company's revenue is derived from three main segments: Structural Heart Diseases Business generating CN¥527.58 million, Peripheral Vascular Diseases Business contributing CN¥751.11 million, and Cardiac Pacing and Electrophysiology Business with CN¥25.01 million. Market Cap: HK$10B LifeTech Scientific Corporation, with a market cap of approximately HK$10.04 billion, operates debt-free and demonstrates financial stability by covering its short- and long-term liabilities with CN¥2.3 billion in short-term assets. However, the company faces challenges with negative earnings growth over the past year despite a 7.9% annual profit increase over five years. Its net profit margin has declined to 17.1% from 20.8%, reflecting pressures on profitability, while Return on Equity remains low at 4.8%. Recent board appointments may strengthen governance as LifeTech navigates industry competition amid stable volatility levels in its stock performance. Navigate through the intricacies of LifeTech Scientific with our comprehensive balance sheet health report here. Examine LifeTech Scientific's past performance report to understand how it has performed in prior years. SSY Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: SSY Group Limited is an investment holding company that engages in the research, development, manufacturing, trading, and sale of pharmaceutical products to hospitals and distributors both within the People's Republic of China and internationally, with a market cap of HK$9.06 billion. Operations: The company's revenue is primarily generated from its Intravenous Infusion Solution and Others segment, which accounts for HK$5.59 billion, followed by the Medical Materials segment with HK$405.07 million. Market Cap: HK$9.06B SSY Group Limited, with a market cap of HK$9.06 billion, primarily generates revenue from its Intravenous Infusion Solution segment. Recent approvals by China's National Medical Products Administration for drugs like Fampridine and Drotaverine Hydrochloride highlight the company's active pharmaceutical development strategy. Despite this, SSY faces challenges with negative earnings growth over the past year and a declining net profit margin to 18.4%. The company's financials show stability with short-term assets covering both short- and long-term liabilities, while interest payments are well covered by EBIT. However, dividend sustainability remains a concern due to limited free cash flow coverage. Take a closer look at SSY Group's potential here in our financial health report. Review our growth performance report to gain insights into SSY Group's future. Make It Happen Click this link to deep-dive into the 972 companies within our Asian Penny Stocks screener. Curious About Other Options? Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include Catalist:5TP SEHK:1302 and SEHK:2005. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
33 minutes ago
- Yahoo
AmpliTech Group Inc (AMPG) Q2 2025 Earnings Call Highlights: Record Sales and Strategic ...
Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AmpliTech Group Inc (NASDAQ:AMPG) achieved record sales of over $11 million in Q2 2025, surpassing total sales for the entire 2024 fiscal year. The company has a strong financial position with $16,423,000 in cash and cash equivalents and no long-term debt. AmpliTech Group Inc (NASDAQ:AMPG) has secured multiple purchase orders and LOIs with prominent 5G players, indicating strong future revenue potential. The company is strategically positioned to benefit from major US government initiatives, including rural broadband funding and the CHIPS Act. AmpliTech Group Inc (NASDAQ:AMPG) is the only US-based company providing complete vertically integrated end-to-end commercial and defense-grade networking solutions, offering a trusted alternative to foreign suppliers. Negative Points The company experienced lower than normal gross profit margins in Q2 2025 due to front-loaded investments and one-time costs. AmpliTech Group Inc (NASDAQ:AMPG) incurred several one-time costs, including license fees and initial production line fees, which impacted profitability. The quantum computing business is not yet at a production phase, limiting immediate revenue potential from this segment. The satellite business is expected to start generating revenue only next year, indicating a delay in realizing returns from this division. The company had to expedite material and pay premiums to meet Q2 delivery requirements, which increased costs and affected margins. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with AMPG. Q: Can you provide more details on the orders from the second tier one customer and the expected timeline for additional orders? A: We have already received orders from the second tier one customer, which are part of our backlog. We have two main Letters of Intent (LOIs), one for $170 million and another for $40 million. We have actively shipped against the $40 million LOI during Q2 and received additional orders for production quantities for this year and the start of next year. For the $170 million LOI, we have received about $2.5 million worth of orders, with the bulk expected between 2026 and 2027. George Flores, COO Q: How is the pipeline looking with other operators around the world? A: While we can't provide specific numbers, the transition to 5G OAN technology is imminent for many other MNOs. Our successful implementation with current partners has made it more viable for other large MNOs to pursue this opportunity. We expect a positive response from other MNOs next year. Pava McGul, CEO Q: Can you update us on the progress in the quantum computing space? A: Quantum computing is not yet at a production phase. We have delivered products to large companies, but the market is still in R&D. Quantum computing will eventually power AI, replacing current silicon applications. When production ramps up, our components will be essential, but this is not expected immediately. Pava McGul, CEO Q: What is the status of your space division and the backlog for next year? A: Our space products are geared towards low Earth orbit applications. The satellite business is expected to start next year as satellites are being built out. We have developed space-qualified hardware to support these applications, but significant demand is anticipated to begin next year. Pava McGul, CEO Q: How are you managing inventory and manufacturing to meet demand? A: We have a strong relationship with our customers, allowing us to see their forecasts and activate our supply chain accordingly. This has helped us avoid expediting costs and manage inventory effectively. We are building to order and keeping inventory levels manageable to support upcoming orders across our divisions. George Flores, COO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
